EUVIMEDEUVIMED entdecken
Open Access

Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels

Hiroki Okamoto, Kazuhiro Yoshikawa, Akiko Shimada, Rui Sano, Daisuke Inukai, Shunpei Yamanaka, Susumu Suzuki, Ryuzo Ueda, Hiromi Ueda, Yasushi Fujimoto, Tetsuya Ogawa

Oncology Reports · 2023

DOI: 10.3892/or.2023.8591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Hiroki Okamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology‑Head and Neck Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi 480‑1195, Japan. Hauptthemen laut MEDLINE: Artemisinins, Head and Neck Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsHead and Neck NeoplasmsHumansAgedCisplatinArtesunateSquamous Cell Carcinoma of Head and NeckCell ProliferationCell CycleApoptosisIron

Stichwörter der Autor:innen

anti‑malarial drugsartesunatecisplatinhead and neck squamous cell carcinomaretinoblastoma

Substanzen

CisplatinArtesunateArtemisininsartemisininIron

Autor:innen und Institutionen

  • Department of Otorhinolaryngology‑Head and Neck Surgery, Aichi Medical University School of Medicine, Nagakute, Aichi 480‑1195, Japan.
  • Division of Biobank, Research Creation Support Center, Aichi Medical University, Nagakute, Aichi 480‑1195, Japan.
  • Division of Research Creation, Research Creation Support Center, Aichi Medical University, Nagakute, Aichi 480‑1195, Japan.
  • Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi 480‑1195, Japan.

Zitieren

APA

Okamoto, H., Yoshikawa, K., Shimada, A., Sano, R., Inukai, D., Yamanaka, S., Suzuki, S., Ueda, R., Ueda, H., Fujimoto, Y., & Ogawa, T. (2023). Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels. Oncology Reports. https://doi.org/10.3892/or.2023.8591

Vancouver

Okamoto H, Yoshikawa K, Shimada A, Sano R, Inukai D, Yamanaka S, et al. Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels. Oncology Reports. 2023. doi:10.3892/or.2023.8591

BibTeX
@article{Okamoto2023,
  author = {Okamoto, Hiroki and Yoshikawa, Kazuhiro and Shimada, Akiko and Sano, Rui and Inukai, Daisuke and Yamanaka, Shunpei and Suzuki, Susumu and Ueda, Ryuzo and Ueda, Hiromi and Fujimoto, Yasushi and Ogawa, Tetsuya},
  title = {Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels},
  journal = {Oncology Reports},
  year = {2023},
  doi = {10.3892/or.2023.8591}
}
Kostenlos starten →